Collaboration Goals. The Collaboration has the following goals: • To support and advance the mission of each Party through exchange and transfer of knowledge and expertise; • To be thought leaders, creating intellectual capital that shapes and influences debate and leads to actions that advance identity management, data privacy, and security innovation; • To improve public and private sector trust and ability to adopt innovations in the United States, Canada, and globally through the development of research projects, pilots, and proofs of concept.
Collaboration Goals. Pursuant and subject to the terms of this Agreement, within the Field and the Territory, the Parties agree to: (a) engage in Development activities with the goal of obtaining Regulatory Approval for Antegren or, as applicable, other Licensed Product, as soon as reasonably practicable, in one or more Commercially Significant Indications in each Major Market Country where it makes commercial sense to do so given the size of the potential market and the safety and efficacy profile of Licensed Product and (b) engage in Commercialization of Antegren, or, as applicable, other Licensed Product, with the goal of optimizing the profit available to each Party. For purposes of clarity, it is understood by the Parties that the JCT may decide that it does not make commercial sense for the Parties to Develop or Commercialize Licensed Product in a particular Major Market Country in a given indication. Each Party agrees to use Commercially Reasonable and Diligent Efforts in performing its tasks and responsibilities and in conducting all activities ascribed or assigned to it under this Agreement, the then current Development Plan, any Annual Work Plan/Budget, the then current Commercialization Plan and any Annual Commercialization Plan/Budget. Each Party shall cooperate with and provide reasonable support to the other Party in performing its activities with respect to the Development and Commercialization work contemplated hereunder. Each Party agrees, during the Term, to Develop, manufacture, Commercialize and Promote Licensed Products only under the terms of this Agreement. The Parties' intent is to Develop, Commercialize, manufacture and Promote Antegren or, as applicable, other Licensed Product, as expeditiously as reasonably practicable with the resources and responsibilities allocated between the Parties on the basis of each Party's respective capabilities and availability of adequate capacities, either internally or through such subcontractors as are customarily used by a Party. Unless otherwise specified in this Agreement, the guiding principles to be followed by the JSC, the Joint Project Team and the JCT are as follows: achieve synergy and avoid duplication of resources; maximize the profitability of Antegren or, as applicable, other Licensed Product, over its life; and utilize, to the extent practicable, the then-prevailing infrastructure and expertise of each Party with respect to specific Development activities and any specific indication and utilize, on a cou...
Collaboration Goals. Pursuant and subject to the terms of this Agreement and the TTA, the Parties agree: (a) that NovaMedica (i) engages in Development activities with the goal of obtaining Regulatory Approval for any of the Covered Products, as soon as reasonably practicable, in the Territory and (ii) thereafter conducts the Commercialization of the Covered Products in the Territory, and (b) that Company (i) through its membership on the JSC, JDC and JCC, participates in the planning and oversight of such Development and Commercialization activities and (ii) provides such other assistance as is set forth in this Agreement and the TTA. Notwithstanding anything in this Agreement to the contrary, either Party shall be free to work alone or with Third Parties to research, develop, manufacture and/or commercialize any product that is not a Covered Product in or outside the Field.
Collaboration Goals. Pursuant and subject to the terms of this Agreement, within the Field and the Territory, the Parties agree to collaborate in the Development and Commercialization of Covered Product each supporting the Joint Steering, Development and Commercialization Team activities as outlined in Section 3. All other advice and assistance shall be mutually agreed by the Parties. NovaMedica shall promptly reimburse Marinus for all Out-of-Pocket Expenses incurred by Marinus in performing its obligations under this Agreement according to its terms. Notwithstanding anything in this Agreement to the contrary, NovaMedica shall be free to work alone or with Third Parties to research, develop, manufacture and/or commercialize any product that is not a Covered Product in or outside the Field in the Territory in accordance with the TTA, and Marinus shall be free to work alone or with Third Parties to research, develop, manufacture and/or commercialize any Covered Product outside the Territory and any and all products that are not a Covered Product anywhere in the world. Consistent with the TTA, Marinus shall have no obligation to perform any clinical trials in the Territory, except to the extent expressly agreed in writing by the Parties.
Collaboration Goals. The Parties agree, pursuant and subject to the terms of this Agreement, to develop Licensed Products, with the goal of obtaining Regulatory Approval of Licensed Products in commercially significant indications as soon as reasonably practicable for commercial marketing and sale in the Field in the Territory, pursuant to this Agreement. Each Party shall use Commercially Reasonable and Diligent Efforts to perform its respective tasks and obligations in conducting all development work ascribed to it in the Development Budget/Plan, and each Party shall cooperate with and provide reasonable support to the other Party in such other Party's conduct of such development and commercialization work as provided in the Development Budget/Plan.
Collaboration Goals. 19 2.2 Exclusive Working Relationship......................................19
Collaboration Goals. Pursuant and subject to the terms of this Agreement, the Parties agree to: (a) engage in discovery and Research activities with the goal of identifying one or more R&D Candidates in the Field, (b) engage in Development activities with the goal of obtaining Regulatory Approval for Collaboration Products in the Territory where it makes commercial sense to do so given the size of the potential market and the safety and efficacy profile of each Collaboration Product and (c) engage in Commercialization of Collaboration Products with the goal of optimizing the profit available to each Party. For purposes of clarity, it is understood by the Parties that the JSC may decide that it does not make commercial sense for the Parties to Develop or Commercialize a Collaboration Product in a particular country in the Territory. Each Party agrees to use Commercially Reasonable Efforts in performing its tasks and responsibilities and in conducting all activities ascribed or assigned to it under this Agreement, the then current Annual Research Plan, Annual Development Plan, any Annual Research Budget, Annual Development Budget, the then current Commercialization Plan and any Annual Commercialization Plan. Each Party shall cooperate with and provide reasonable support to the other Party in performing its activities with respect to the Research, Development and Commercialization work contemplated hereunder. Each Party agrees, during the term of this Agreement, to Develop, Manufacture, and Commercialize, as applicable, Collaboration Products, Party Exclusive Products and Non-Antibody Products, only under the terms of this Agreement.
Collaboration Goals. (a) Pursuant and subject to the terms of this Agreement:
Collaboration Goals. Consistent with the TTA and subject to the terms and conditions set forth herein, Regado agrees to assist NovaMedica in the Development and Commercialization of Covered Products in the Territory. Notwithstanding anything in this Agreement to the contrary, either Party shall be free to work alone or with Third Parties to research, develop, manufacture and/or commercialize any product that is not a Covered Product in or outside the Field.
Collaboration Goals. Achieving a stronger, more equitable tech cluster in which residents in Atlanta from all backgrounds can build wealth is a process that cannot be completed by any individual organization. Current solutions, as evidenced in the prior discussion on mitigations, are primarily siloed. In the private sector, organizations, and individuals in Atlanta work towards strengthening the resources of the tech cluster through the development of new accelerator programs or deployment of capital. Other private nonprofits, like the AWBI, also work to outline and remediate the potential externalities that may result in improving Atlanta’s tech cluster. The case 233 “Start:ME Atlanta - Grow Your Small Business,” Start:ME Atlanta, accessed March 29, 2021, https://www.startmeatl.org. of the public sector is similar: divisions of government like Invest Atlanta work to improve access to resources for the city’s entrepreneurs, while other divisions work to mitigate the externalities. In both cases, there is a lack of collaboration, which effectively stagnates the development of new, innovative solutions. The primary goal of collaboration is to increase the capacity by which Atlanta city government can deploy more resources to critical services like education. The second goal of collaboration is to foster stronger connections and integrations between corporations and local businesses to achieve inclusive prosperity in Atlanta.
